Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report_116_treasury_shares_espi.pdfNotification for sale of treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 116 / 2025
Date of issue: 2025-08-15
Short name of the issuer
SOPHARMA AD
Subject
Notification for sale of treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 14, 2025 the Company sold 7 450 (seven thousand four hundred and fifty) treasury shares representing 0.001% of the share capital of the Company, at a total value of BGN 18 252.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.
Annexes
File Description
Current report_116_treasury_shares_espi.pdf
Current report_116_treasury_shares_espi.pdf		 Notification for sale of treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-08-15 Ognian Ivanov Donev Executive Director
20250815_090103_1635609264_Current_report_116_treasury_shares_espi.pdf

Pobierz